Director sold ~$140K of Teradyne
Scheduled in advanceLoading…
Reporting person on SEC Form 4
Marilyn Matz
Marilyn Matz is Director at Teradyne. OQRO lists 8 transactions filed with the SEC under this name, the latest on Sep 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
8
Companies involved
1
Disclosure history
Director sold ~$270K of Teradyne
Scheduled in advanceDirector sold ~$510K of Teradyne
Scheduled in advanceDirector sold ~$428K of Teradyne
Scheduled in advanceDirector sold ~$508K of Teradyne
Scheduled in advanceDirector sold ~$140K of Teradyne
Scheduled in advanceDirector sold ~$271K of Teradyne
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.